Bizalimogene ralaplasmid (Inovio Pharmaceuticals)

N/A

Report date: 2026/05/26 20:00:28

Base Information

Drug NameBizalimogene ralaplasmid (Inovio Pharmaceuticals)
Drug Alias NameHuman papillomavirus vaccine (Inovio Pharmaceuticals)Bizalimogene ralaplasmid (Inovio Pharmaceuticals)Mavilimogene ralaplasmid (Inovio Pharmaceuticals)pGX-3002pGX 3001 +[7] 
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Application > Therapeutic vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsVaginal intraepithelial neoplasiaAnal intraepithelial neoplasiaVulvar Diseases +[12] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[26] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesUniversity Of Pennsylvania
China Registration ClassN/A

Develop Information

Active CompaniesInovio Pharmaceuticals IncApolloBio CorpAlliance Medical Products Inc +[4] 
Inactive CompaniesN/A
Active IndicationsVaginal intraepithelial neoplasiaAnal intraepithelial neoplasiaUterine Cervical Incompetence +[6] 
Inactive IndicationsVulvar DiseasesUrogenital AbnormalitiesPrecancerous Conditions +[6] 

Other Information

ATC CodeN/A
Related LinksN/A